CLINICAL_TRIALS
trial_result
· 2020-07-22
Clinical Trial Update: A Study of Ixekizumab in Chinese Participants With Psoriasis Vulgaris [Phase 1]
Summary
Phase 1 clinical trial update for ixekizumab in Chinese participants with psoriasis vulgaris has been completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Psoriasis | Phase 1 | Status: COMPLETED | Results posted: 2020-07-22